[Small renal cell carcinoma-active surveillance and ablation]

Autor: J J, Wendler, R, Damm, U-B, Liehr, T, Brunner, M, Pech, M, Schostak

Publikováno v: Der Urologe. Ausg. A. 57(6)

The incidence of renal cell carcinoma has been rising for years. At the same time there is an increasing prevalence of chronic renal failure with subsequent higher morbidity and shorter life expectancy in those affected. In the last decades the gold

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::caecf033ab155255e0840fbd1d01e973
https://pubmed.ncbi.nlm.nih.gov/29796702

[Focal therapy for small renal masses : Observation, ablation or surgery]

Autor: J J, Wendler, B, Friebe, D, Baumunk, A, Blana, T, Franiel, R, Ganzer, B, Hadaschik, T, Henkel, K U, Köhrmann, J, Köllermann, T, Kuru, S, Machtens, A, Roosen, G, Salomon, H P, Schlemmer, L, Sentker, U, Witzsch, U B, Liehr, J, Ricke, M, Schostak

Publikováno v: Der Urologe. Ausg. A. 55(5)

The rising incidence of renal cell carcinoma, its more frequent early detection (stage T1a) and the increasing prevalence of chronic renal failure with higher morbidity and shorter life expectancy underscore the need for multimodal focal nephron-spar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dff03276efc17629904e994ffba529c8
https://pubmed.ncbi.nlm.nih.gov/27126677

Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project

Autor: Mihir M. Desai, J. J. Wendler, Jens Köllermann, J.J.M.C.H. de la Rosette, H. P. Schlemmer, Peter G. K. Wagstaff, Sascha Pahernik, Uwe-Bernd Liehr, Ferran Algaba, Patricia J. Zondervan, A. F. Fraga, Daniel M. de Bruin, M.P. Laguna Pes, Boris Hadaschik

Publikováno v: WORLD JOURNAL OF UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
World journal of urology, 34(12), 1657-1665. Springer Verlag
World Journal of Urology

Purpose To establish consensus on follow-up (FU) after focal therapy (FT) in renal masses. To formulate recommendations to aid in clinical practice and research. Methods Key topics and questions for consensus were identified from a systematic literat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7517054d4bea35d74ae5c4bda166f7f8
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6894

[High-intensity focussed ultrasound in low-risk prostate cancer - oncological outcome and postinterventional quality of life of an inexperienced therapy centre in comparison with an experienced therapy centre]

Autor: D, Baumunk, C, Andersen, U, Heile, J, Ebbing, H, Cash, M, Porsch, U-B, Liehr, A, Janitzky, J J, Wendler, D, Schindele, S, Blaschke, K, Miller, M, Schostak

Publikováno v: Aktuelle Urologie. 44(4)

In patients with low-risk prostate cancer (PCa) the standard therapies carry a risk of overtreatment with potentially preventable side effects whereas restrained therapeutic strategies pose a risk of underestimation of the individual cancer risk. Alt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::15eea16eb95e24b5e7ca89a682b0da9b
https://pubmed.ncbi.nlm.nih.gov/23888408

[Irreversible electroporation: the new generation of local ablation techniques for renal cell carcinoma]

Autor: U-B, Liehr, J J, Wendler, S, Blaschke, M, Porsch, A, Janitzky, D, Baumunk, M, Pech, F, Fischbach, D, Schindele, C, Grube, J, Ricke, M, Schostak

Publikováno v: Der Urologe. Ausg. A. 51(12)

Local ablation techniques are a major focus of current developments in oncology. The primary aim is to retain organs and preserve organ functions without compromising the oncological outcome.Irreversible electroporation (IRE) is a novel ablation tech

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::db27350534cba549bb8d45b10b403838
https://pubmed.ncbi.nlm.nih.gov/23139026